Triple-Targeted Peptide–Photosensitizer–Drug Conjugate Enables NIR-II Imaging-Guided Multimodal Therapy Against Osteosarcoma
ACS Nano · 2026
DOI: 10.1021/acsnano.6c01282 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Xiaofan He und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China. Hauptthemen laut MEDLINE: Osteosarcoma, Photosensitizing Agents, Antineoplastic Agents, Bone Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: Wuxi Health and Family Planning Commission, Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China.
- Wuxi Key Laboratory of Biomaterials for Clinical Application, Key Laboratory for Multidisciplinary Intersection of Radiotherapy and Immunology for Gastrointestinal Tumor, Department of Central Laboratory, Jiangyin Clini…
- State Key Laboratory of Organic Electronics and Information Displays & Institute of Advanced Materials (IAM) Jiangsu Key Laboratory for Biosensors, Nanjing University of Posts & Telecommunications, Nanjing 210023, China.
- Bozhou UK Biomedical Technology Co LTD., Bozhou 236800, China.
- State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun 130012, China.
ORCID-Profile: Xiaofan He
Förderung
- Wuxi Health and Family Planning Commission
- Natural Science Foundation of Jiangsu Province
- National Natural Science Foundation of China
- Affiliated Hospital of Xuzhou Medical University
Zitieren
APA
He, X., Liang, X., Yu, J., Rong, J., Hu, J., Xu, C., Cai, Z., Chen, J., Zhang, Y., Pu, X., Sun, P., Wu, H., & Sun, B. (2026). Triple-Targeted Peptide–Photosensitizer–Drug Conjugate Enables NIR-II Imaging-Guided Multimodal Therapy Against Osteosarcoma. ACS Nano. https://doi.org/10.1021/acsnano.6c01282
Vancouver
He X, Liang X, Yu J, Rong J, Hu J, Xu C, et al. Triple-Targeted Peptide–Photosensitizer–Drug Conjugate Enables NIR-II Imaging-Guided Multimodal Therapy Against Osteosarcoma. ACS Nano. 2026. doi:10.1021/acsnano.6c01282
BibTeX
@article{He2026,
author = {He, Xiaofan and Liang, Xiao and Yu, Jiaying and Rong, Jie and Hu, Jinzhong and Xu, Chensen and Cai, Zhuoer and Chen, Jian and Zhang, Yinan and Pu, Xin and Sun, Pengfei and Wu, Hongshuai and Sun, Baiwang},
title = {Triple-Targeted Peptide–Photosensitizer–Drug Conjugate Enables NIR-II Imaging-Guided Multimodal Therapy Against Osteosarcoma},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c01282}
}
EUVIMED